Mechanisms of methamphetamine-induced dopamine terminal degeneration

Update Item Information
Publication Type dissertation
School or College School of Medicine
Department Neurology
Author Friend, Danielle M.
Title Mechanisms of methamphetamine-induced dopamine terminal degeneration
Date 2013-08
Description Although it is well known that METH damages the dopamine (DA) system, the mechanisms underlying such toxicity have not been elucidated. Previous work indicates that animals with partial DA loss from prior exposure to METH are resistant to further decreases in DA when reexposed to METH 30 days later. This experimental paradigm results in four treatment groups based on postnatal day (PND)60:PND90 treatment (Saline:Saline, METH:Saline, Saline:METH, METH:METH) and allows for examination of factors associated with METH toxicity in animals matched for METH exposure, but differentiated with respect to acute METH neurotoxicity. We used this paradigm to examine factors implicated in METH-induced neurotoxicity. First, we investigated the possible contribution of nitric oxide (NO) by examining nitric oxide synthase (NOS) expression, activity, and protein nitration. We found that acute METH administration increased NO production; however, METH did not change expression of endothelial NOS or result in induction of inducible NOS. The number of cells positive for neuronal (nNOS) mRNA or the amount of nNOS mRNA per cell also did not change. However, NOS activity was increased acutely after METH exposure, suggesting that increased NO production after METH exposure arises from NOS activity and most likely, nNOS. Furthermore, animals resistant to METH-induced DA depletions show equivalent degrees of NO production, suggesting that NO alone is not sufficient to induce METH-induced neurotoxicity. Using the same paradigm, we then examined glial reactivity using glialfibrillary acidic protein (GFAP; astrocytes) and CD11b (Microglia), as well as markers of proliferation (BrdU and Ki67) immunohistochemistry. Animals experiencing acute toxicity (Saline:METH) showed activated microglia and astocytes, whereas those resistant to toxicity (METH:METH) did not show activated microglia. Furthermore, animals experiencing acute toxicity (Saline:METH) also showed increased proliferation compared to all other groups and a large proportion of proliferating cells were microglia with a smaller proportion being astrocytes. Interestingly, GFAP expression remained elevated in animals exposed to METH at PND60 (METH:Saline), and was not further elevated in resistant animals (METH:METH). These data suggest that astrocytes remain reactive up to 30 days post-METH exposure and that astrocyte reactivity does not reflect acute METH-induced neurotoxicity whereas microglial reactivity parallels acute METHinduced neurotoxicity.
Type Text
Publisher University of Utah
Subject MESH Substance-Related Disorders; Neurotoxicity Syndromes; Dopamine; Immunohistochemistry; Nitric Oxide; RNA, Messenger; Bromodeoxyuridine; Astrocytes; Microglia
Dissertation Institution University of Utah
Dissertation Name Doctor of Philosophy
Language eng
Relation is Version of Digital reproduction of Mechanisms of Methamphetamine-Induced Dopamine Terminal Degenration. Spencer S. Eccles Health Sciences Library. Print version available at J. Willard Marriott Library Special Collections.
Rights Management Copyright © Danielle M. Friend 2013
Format Medium application/pdf
Format Extent 3,998,369 bytes
Source Original in Marriott Library Special Collections, RM31.5 2013.F75
ARK ark:/87278/s6p87m4c
Setname ir_etd
ID 196602
Reference URL https://collections.lib.utah.edu/ark:/87278/s6p87m4c
Back to Search Results